Thomas Okarma gave the keynote address at the 2010 World Stem Cell Summit. He spoke about his company’s research and future plans for treating those with spinal injuries. The Geron Corporation had received permission from the FDA to begin the world’s first human clinical trial to test embryonic stem cells as a treatment for spinal cord injuries.
Recent Posts
- Improving CAR-T therapy from within
- ‘A cure on the horizon’: Are we finally close to ending type 1 diabetes?
- Scientists create “smart” DNA drug that targets cancer cells with extreme precision
- Patient deaths prompt concern over regenerative care not covered by insurance
- Biotech IPOs Rebound as AI Takes a More Central Role in Drug Development
- Clinical trial tests new cell therapy to manage kidney transplant rejection
